AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

MacKenzie Realty Capital, Inc.

$1.45 -$2.93 (-66.89%)
NASDAQ · 14 Sep 2026 20:00 UTC
Previous Close
$1.44
Day Range
$1.45$1.48
Year Range
$0.83$6.99
Market Cap
3.27M
AVG Volume
51.18K
Trailing/Forward PE
-0.13/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
010M20M30M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
MKZR Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q319.32M
26 Q218.18M
26 Q121.65M
25 Q422.06M
25 Q321.78M
25 Q221.58M
25 Q117.13M
24 Q415.74M
24 Q315.11M
24 Q215.5M
Net Income (USD) · TTM
-30M-20M-10M010M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
MKZR Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q3-17.48M
26 Q2-22.38M
26 Q1-22.19M
25 Q4-25.92M
25 Q3-22.17M
25 Q2-18.83M
25 Q1-15.56M
24 Q4-12.08M
24 Q3651.02K
24 Q2-6.43M
Operating Income (USD) · TTM
-30M-20M-10M024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
MKZR Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q3-13.2M
26 Q2-19.36M
26 Q1-14.98M
25 Q4-14.4M
25 Q3-13.39M
25 Q2-10.24M
25 Q1-15.1M
24 Q4-9.92M
24 Q3-18.84M
24 Q2-25.4M
EBITDA (USD) · TTM
-5M05M10M15M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
MKZR EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q34.87M
26 Q2491.15K
26 Q1-646.9K
25 Q4-4.01M
25 Q3-2.98M
25 Q2-1.63M
25 Q1145.25K
24 Q42.05M
24 Q314.32M
24 Q27.09M
Cash Flows (USD) · TTM
-10M-5M05M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
MKZR Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q3-4.39M
26 Q2-7.8M
26 Q1-4.35M
25 Q4-1.69M
25 Q3-806.15K
25 Q22.51M
25 Q1-468.22K
24 Q4-595.52K
24 Q3-1.55M
24 Q2-3.73M
EPS (USD) · TTM
-20-15-10-5024 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
MKZR EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q3-10.91
26 Q2-14.63
26 Q1-15.56
25 Q4-19.46
25 Q3-16.87
25 Q2-14.77
25 Q1-12.37
24 Q4-9.77
24 Q3-0.2
24 Q2-5.5
Expenses (USD) · TTM
02M4M6MSG&ACapex24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
MKZR Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q33.01M
26 Q24.69M
26 Q14.92M
25 Q45.22M
25 Q34.51M
25 Q23.07M
25 Q12.91M
24 Q42.56M
24 Q32.65M
24 Q22.64M
Shares Outstanding (USD) · TTM
-1M01M2MBuybacks (Repurchases)Stock-Based Compensation24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
MKZR Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q3-60.76K
26 Q2-588.94K
26 Q1-583.42K
25 Q4-622.58K
25 Q3-494.63K
25 Q2553.5K
25 Q11.03M
24 Q41.48M
24 Q31.91M
24 Q21.81M
Dividends (USD)
00.511.5Sep 23Jun 24Sep 24Dec 24Mar 25
MKZR Dividends (USD) by quarter
PeriodDividends (USD)
Mar 250.5
Dec 240.5
Sep 241.25
Jun 241.25
Sep 231.25
PE Ratio
4050607080med 61.2Jul 24Jul 24Aug 24Aug 24Sep 24Sep 24
MKZR PE Ratio by quarter
PeriodPE Ratio
Sep 2465.89
Sep 2459.57
Sep 2470.38
Aug 2465.28
Aug 2474.26
Aug 2454.88
Aug 2452.63
Aug 2461.2
Jul 2448.96
Jul 2458.14
Jul 2470.18
Free Cash Flow Yield
-300%-200%-100%0%100%med -21.21%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
MKZR Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-145.78%
Sep 26-146.79%
Sep 26-139.06%
Aug 26-139.98%
Aug 26-143.79%
Aug 26-130.48%
Aug 26-128.89%
Jul 26-205.22%
Jul 26-135.5%
Jul 26-126.57%
Jul 26-122.89%
Jul 26-118.75%
Jun 26-125.07%
Jun 26-125.07%
Jun 26-93.95%
Jun 26-90.72%
May 26-89.57%
May 26-86.63%
May 26-89.95%
May 26-167.92%
May 26-149.93%
Apr 26-128.38%
Apr 26-112.24%
Apr 26-128.77%
Apr 26-124.94%
Mar 26-116.29%
Mar 26-106.01%
Mar 26-111.65%
Mar 26-115.01%
Feb 26-104.69%
Feb 26-108.19%
Feb 26-60.46%
Feb 26-59.39%
Jan 26-54.42%
Jan 26-50.66%
Jan 26-48.17%
Jan 26-47.39%
Jan 26-53.56%
Dec 25-60.3%
Dec 25-57.35%
Dec 25-53.43%
Dec 25-62.89%
Nov 25-56.93%
Nov 25-56.66%
Nov 25-49.49%
Nov 25-23.6%
Oct 25-23.6%
Oct 25-22.18%
Oct 25-21.64%
Oct 25-20.78%
Oct 25-22.1%
Sep 25-10.5%
Sep 25-10.15%
Sep 25-9.38%
Sep 25-9.46%
Aug 25-8.95%
Aug 25-10.46%
Aug 25-11.26%
Aug 25-11.47%
Aug 25-10.9%
Jul 25-8.67%
Jul 25-8.15%
Jul 25-8.15%
Jul 25-8.52%
Jun 25-8.2%
Jun 25-8.64%
Jun 25-7.58%
Jun 25-6.23%
May 25-5.69%
May 25-6.36%
May 25-5.01%
May 2517.1%
May 2515.28%
Apr 2516.21%
Apr 2515.67%
Apr 2513.81%
Apr 2513.32%
Mar 2512.03%
Mar 2511.37%
Mar 259.97%
Mar 258.75%
Feb 2510.53%
Feb 259.66%
Feb 257.77%
Feb 25-1.74%
Jan 25-1.62%
Jan 25-1.52%
Jan 25-1.46%
Jan 25-1.3%
Jan 25-1.28%
Dec 24-0.9%
Dec 24-0.72%
Dec 24-0.79%
Dec 24-1.08%
Nov 24-1.08%
Nov 24-1.11%
Nov 24-0.97%
Nov 24-1.27%
Nov 24-1.24%
Oct 24-1.24%
Price to Sales
01234med 0.39Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
MKZR Price to Sales by quarter
PeriodPrice to Sales
Sep 260.16
Sep 260.15
Sep 260.16
Aug 260.16
Aug 260.16
Aug 260.17
Aug 260.18
Jul 260.11
Jul 260.17
Jul 260.18
Jul 260.19
Jul 260.19
Jun 260.18
Jun 260.18
Jun 260.24
Jun 260.25
May 260.25
May 260.26
May 260.25
May 260.26
May 260.29
Apr 260.33
Apr 260.38
Apr 260.33
Apr 260.34
Mar 260.37
Mar 260.4
Mar 260.38
Mar 260.37
Feb 260.41
Feb 260.4
Feb 260.33
Feb 260.34
Jan 260.37
Jan 260.4
Jan 260.42
Jan 260.42
Jan 260.38
Dec 250.33
Dec 250.35
Dec 250.38
Dec 250.32
Nov 250.35
Nov 250.35
Nov 250.41
Nov 250.32
Oct 250.32
Oct 250.35
Oct 250.35
Oct 250.37
Oct 250.35
Sep 250.35
Sep 250.36
Sep 250.39
Sep 250.39
Aug 250.41
Aug 250.35
Aug 250.33
Aug 250.32
Aug 250.34
Jul 250.43
Jul 250.45
Jul 250.45
Jul 250.43
Jun 250.45
Jun 250.43
Jun 250.49
Jun 250.59
May 250.65
May 250.58
May 250.74
May 250.68
May 250.76
Apr 250.72
Apr 250.74
Apr 250.84
Apr 250.87
Mar 250.97
Mar 251.02
Mar 251.17
Mar 251.33
Feb 251.1
Feb 251.2
Feb 251.5
Feb 251.57
Jan 251.68
Jan 251.8
Jan 251.88
Jan 252.1
Jan 252.14
Dec 243.02
Dec 243.77
Dec 243.47
Dec 242.53
Nov 242.52
Nov 242.47
Nov 242.83
Nov 242.97
Nov 243.04
Oct 243.04
EV/EBITDA
050010001500med 74.63Aug 24Nov 24Jan 25Mar 26May 26Jul 26Sep 26
MKZR EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2629.75
Sep 2629.74
Sep 2629.78
Aug 2629.77
Aug 2629.76
Aug 2629.82
Aug 2629.83
Jul 2629.57
Jul 2629.8
Jul 2629.84
Jul 2629.86
Jul 2629.89
Jun 2629.85
Jun 2629.85
Jun 2630.09
Jun 2630.12
May 2630.14
May 2630.17
May 2630.13
May 26295.86
May 26296.99
Apr 26298.77
Apr 26300.55
Apr 26298.73
Apr 26299.11
Mar 26300.06
Mar 26301.38
Mar 26300.62
Mar 26300.21
Feb 26301.57
Feb 26301.08
Feb 251026.59
Jan 251039.45
Jan 251053.23
Jan 251062.42
Jan 251089.07
Jan 251093.66
Dec 241197.49
Dec 241285.69
Dec 241249.86
Dec 241139.6
Nov 241138.68
Nov 241132.25
Nov 241174.52
Nov 2474.69
Nov 2475.21
Oct 2475.21
Oct 2474.95
Oct 2474.95
Oct 2474.56
Sep 2476.05
Sep 249.61
Sep 249.32
Sep 249.82
Aug 249.58
Aug 249.99
Aug 249.11
Aug 249.01
Aug 249.4
Jul 248.84
Jul 249.26
Jul 249.81
Price/Operating Cashflow
468101214med 8.31Feb 25Feb 25Mar 25Mar 25Apr 25Apr 25May 25
MKZR Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
May 255.85
May 256.54
Apr 256.17
Apr 256.38
Apr 257.24
Apr 257.51
Mar 258.31
Mar 258.8
Mar 2510.03
Mar 2511.43
Feb 259.49
Feb 2510.35
Feb 2512.87
Price to Book
00.20.40.60.8med 0.09Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
MKZR Price to Book by quarter
PeriodPrice to Book
Sep 260.04
Sep 260.04
Sep 260.04
Aug 260.04
Aug 260.04
Aug 260.04
Aug 260.04
Jul 260.03
Jul 260.04
Jul 260.04
Jul 260.04
Jul 260.04
Jun 260.04
Jun 260.04
Jun 260.05
Jun 260.06
May 260.06
May 260.06
May 260.06
May 260.05
May 260.06
Apr 260.07
Apr 260.08
Apr 260.07
Apr 260.07
Mar 260.08
Mar 260.09
Mar 260.08
Mar 260.08
Feb 260.09
Feb 260.08
Feb 260.08
Feb 260.08
Jan 260.09
Jan 260.09
Jan 260.1
Jan 260.1
Jan 260.09
Dec 250.08
Dec 250.08
Dec 250.09
Dec 250.08
Nov 250.08
Nov 250.08
Nov 250.1
Nov 250.08
Oct 250.08
Oct 250.08
Oct 250.08
Oct 250.09
Oct 250.08
Sep 250.08
Sep 250.08
Sep 250.09
Sep 250.09
Aug 250.09
Aug 250.08
Aug 250.07
Aug 250.07
Aug 250.08
Jul 250.09
Jul 250.1
Jul 250.1
Jul 250.1
Jun 250.1
Jun 250.1
Jun 250.11
Jun 250.13
May 250.14
May 250.13
May 250.16
May 250.15
May 250.17
Apr 250.16
Apr 250.16
Apr 250.19
Apr 250.19
Mar 250.21
Mar 250.23
Mar 250.26
Mar 250.29
Feb 250.24
Feb 250.27
Feb 250.33
Feb 250.26
Jan 250.28
Jan 250.3
Jan 250.32
Jan 250.35
Jan 250.36
Dec 240.51
Dec 240.63
Dec 240.58
Dec 240.43
Nov 240.42
Nov 240.41
Nov 240.47
Nov 240.43
Nov 240.44
Oct 240.44
MacKenzie Realty Capital, Inc.
MKZR
Stockpicker

Video analysis: MKZR

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: MKZR

Critical Contrast: Office Properties Income Trust (NASDAQ:OPI) & Mackenzie Realty Capital (NASDAQ:MKZR)

defenseworld.net · 11 Aug 2026

Critical Contrast: Office Properties Income Trust (NASDAQ:OPI) & Mackenzie Realty Capital (NASDAQ:MKZR)

Mackenzie Realty Capital (NASDAQ: MKZR - Get Free Report) and Office Properties Income Trust (NASDAQ: OPI - Get Free Report) are both small-cap real estate companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership and profitability. Analyst Recommendations This

Zacks Initiates Coverage of MacKenzie With Neutral Recommendation

zacks.com · 29 Jul 2026

Zacks Initiates Coverage of MacKenzie With Neutral Recommendation

Discover why Zacks rates MacKenzie as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore MKZR's improving operations and stabilized multifamily assets amid execution challenges and portfolio concentration.

MacKenzie Realty Capital completes successful tender offer; MacKenzie Apartment Communities declares first dividend

globenewswire.com · 29 Jul 2026

MacKenzie Realty Capital completes successful tender offer; MacKenzie Apartment Communities declares first dividend

ORINDA, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- MacKenzie Realty Capital, Inc. (Nasdaq: MKZR) (“MacKenzie” or the “Company”) today announced that it is under contract to purchase over $1,000,000 in shares of National Healthcare Properties, Inc. (“NHP”) in a tender offer at $7.27 per share. MacKenzie intends to finance this purchase with an additional loan agreement with Streeterville Capital, a division of Chicago Venture Partners within the coming weeks, under terms similar to previous such notes. MacKenzie's tender offer (with its affiliates) for NHP has been so successful that it increased the number of shares it was offering to purchase from 150,000 shares to 300,000.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.